# Hubei Biocause Heilen Pharmaceutical Co., Ltd. – FDA Inspection, Aug 16, 2019

Source: https://www.keypedia.com/records/fda_inspections/hubei-biocause-heilen-pharmaceutical-co-ltd/19a77013-5b38-4d23-b2ab-d29ad7ccdb22
Source feed: FDA_Inspections

> FDA inspection 1100057 of Hubei Biocause Heilen Pharmaceutical Co., Ltd., August 16, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1100057
- Company Name: Hubei Biocause Heilen Pharmaceutical Co., Ltd.
- Inspection Date: 2019-08-16
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1296860 - 2025-11-14](https://www.keypedia.com/records/fda_inspections/hubei-biocause-heilen-pharmaceutical-co-ltd/7685750d-7146-4508-ba7d-1016d7b01a6d)
- FDA Inspection 871443 - 2013-11-22
- FDA Inspection 571882 - 2009-03-04

## Related Officers

- Issuing Officer

Company: https://www.keypedia.com/companies/hubei-biocause-heilen-pharmaceutical-co-ltd/d226a8c2-7a18-4274-9541-ca7f8b4f84c0

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c